Laddar...

Advertisement

Aldeyra Therapeutics Achieves Goals In Crossover Clinical Trial Of 0.25% Reproxalap Solution

RTTNews | 1143 dagar sedan

Aldeyra Therapeutics Achieves Goals In Crossover Clinical Trial Of 0.25% Reproxalap Solution

(RTTNews) - Aldeyra Therapeutics, Inc. (ALDX) announced Tuesday the achievement of the primary endpoints in a sequence-randomized, double-masked, vehicle-controlled crossover clinical trial of 0.25% reproxalap ophthalmic solution, an investigational new drug candidate, for the treatment of dry eye disease.

Reproxalap was statistically superior to vehicle for each of the two prespecified primary endpoints, ocular redness in a dry eye chamber and Schirmer test, a measure of tear production, after a single day of dosing.

The secondary endpoint of Schirmer test =10 mm responder analysis, which was multiplicity-controlled, was also achieved.

A pre-NDA meeting with the FDA has been scheduled for the third quarter of 2022.

For More Such Health News, visit rttnews.com

Taggar: ALDX

read more

Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma

Aldeyra Therapeutics Gets CRL From FDA For NDA Of ADX-2191 To Treat Primary Vitreoretinal Lymphoma

Biotechnology company Aldeyra Therapeutics, Inc. (ALDX) announced Wednesday the receipt of a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the 505(b)(2) New Drug Application (NDA) of ADX-2191 (methotrexate for injection, USP), an investigational drug candidate, for the treatment of primary vitreoretinal lymphoma (PVRL).

RTTNews | 799 dagar sedan

Japan Stock Market May Extend Winning Streak

Japan Stock Market May Extend Winning Streak

The Japan stock market has moved higher in back-to-back sessions, collecting more than 430 points or 1 percent along the way. The Nikkei 225 now rests just beneath the 42,830-point plateau and it may add to its winnings on Friday.

RTTNews | 4 minuter sedan

South Korea Industrial Output Adds 0.3% In July

South Korea Industrial Output Adds 0.3% In July

Industrial production in South Korea was up a seasonally adjusted 0.3 percent on month in July, Statistics Korea said on Friday.

RTTNews | 4 minuter sedan

KOSPI May Break Through 3,200-Point Level

KOSPI May Break Through 3,200-Point Level

The South Korea stock market has climbed higher in two straight sessions, advancing almost 20 points or 0.6 percent in that span. The KOSPI now sits just shy of the 3,200-point plateau and it may open to the upside again on Friday.

RTTNews | 19 minuter sedan

Japan Data On Tap For Friday

Japan Data On Tap For Friday

Japan is scheduled to release a batch of data on Friday, headlining a busy day for Asia-Pacific economic activity. On tap are July figures for unemployment, industrial production, retail sales, housing starts and construction orders, as well as August data for household confidence and Tokyo inflation.

RTTNews | 1h 19minuter sedan

Euro Climbs Against Majors

Euro Climbs Against Majors

The euro firmed against its major counterparts in the New York session on Thursday.

RTTNews | 1h 50minuter sedan

Swiss Market Ends Marginally Up

Swiss Market Ends Marginally Up

The Switzerland market ended marginally up on Thursday after a choppy ride as stocks swung between gains and losses right through the day's trading session.

RTTNews | 5h 28minuter sedan

European Stocks Close Weak

European Stocks Close Weak

European stocks closed lower on Thursday as the mood remained largely cautious with investors closely following geopolitical news, digesting tech giant Nvidia's earnings, and some crucial economic data from the U.S.

RTTNews | 5h 48minuter sedan

Villkor | Integritet | Webbkarta | Site Map Calendar

© 2025 Myfxbook Ltd. Alla rättigheter reserverade

HIGH RISK WARNING: Valutahandel innebär en hög risknivå som kanske inte är lämplig för alla investerare. Hävstångseffekten skapar ytterligare risker och förlustexponering. Innan du bestämmer dig för att handla med utländsk valuta bör du noga överväga dina investeringsmål, din erfarenhetsnivå och din risktolerans. Du kan förlora en del av eller hela din ursprungliga investering. Investera inte pengar som du inte har råd att förlora. Utbilda dig om de risker som är förknippade med valutahandel och sök råd från en oberoende finansiell eller skatterådgivare om du har några frågor. Alla uppgifter och all information tillhandahålls endast i informationssyfte och är inte avsedda för handelsändamål eller rådgivning. Tidigare resultat är inte en indikation på framtida resultat.